在血液癌症患者中使用真实数据的外部控制研究:系统性审查
Sjoerd J F Hermans1, Niek G van der Maas1, Yvette van Norden1
1Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
JAMA oncology
|August 29, 2024
概括
在血液癌症研究中,现实世界数据 (RWD) 外部控制臂在应用试验标准,定义终点和报告不良事件方面存在局限性,挑战研究结论.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 现实世界的数据
背景情况:
- 在前性研究中,对外部控制臂的真实世界数据 (RWD) 的使用正在增长.
- 与证据标准平衡RWD的优势,如立即可用性,至关重要.
研究的目的:
- 评估RWD研究中使用的方法与标准随机临床试验 (RCT) 方法相比.
- 评估RWD外部控制臂在多大程度上符合血液癌症研究中的证据标准.
主要方法:
- 对比临床试验干预臂与血液癌症中RWD控制臂的研究进行系统审查.
- 搜索了4个电子数据库和谷歌学者 (2000-2023年).
- 包括32项前性研究,包括4306名试验患者和10,594名RWD患者.
主要成果:
- 只有6%的研究使用了前性收集的RWD;22%的人对RWD应用了完整的试验纳入标准.
- 72%的人使用匹配算法,但只有25%的人使用相同的终点标准.
- 终点定义 (38%不同),随访持续时间和不良事件报告的显著变化.
结论:
- 在RWD外部控制臂中观察到应用试验标准,定义终点和报告不良事件的局限性.
- 这些方法上的不一致性可能会挑战从血液癌症中RWD研究中得出的结论的有效性.
- 需要进一步标准化,以确保RWD在临床研究中的可靠性.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.2K
03:40Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
936
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
